Leestijd: < 1 minuutDoor een seinstoring rijden er vandaag voor de tweede keer geen treinen tussen Deventer en Olst. Dit ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

PharmaCord is a Jeffersonville, Indiana-based provider of patient services for the biopharmaceutical industry, and Mercalis, a Morrisville, North Carolina-based provider of life sciences and ...

Robert Truckenmiller will serve as CEO of the combined company ... Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel, and Jefferies LLC and Leerink Partners are serving as financial ...

Jazz Pharmaceuticals’ acquisition of Chimerix brings a drug that could become the first approved therapy for a rare and aggressive form of brain cancer affecting children and young adults.

Leerink analyst Roanna Ruiz initiated coverage of CorMedix (CRMD) with an Outperform rating and $18 price target The firm believes the company’s lead product DefenCath represents a significant ...

Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025 Lexicon Pharmaceuticals, Inc. - (GLOBE NEWSWIRE) Mar 7, 2025 ...

A webcast of the presentation will be accessible in the Investors section of the company’s website at https://www.adagene.com for at least 30 days. About AdageneAdagene Inc. (Nasdaq: ADAG) is ...

today announced that management will present a company overview at the Leerink Partners Global Healthcare Conference on Wednesday, March 12 th at 1:00 p.m. ET. The live webcast can be accessed via ...

Robert Lenz is leaving the brain drug developer to “pursue other interests.” Elsewhere, Atara is cutting half of its staff after shelving two cell therapy programs.

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI initiated coverage with a Buy rating on Icon (ICLR – Research Report) ...

Novocure (NASDAQ: NVCR) announced today that management will participate in the Leerink Global Healthcare Conference on Tuesday, March 11, 2025. Christoph Brackmann, Chief Financial Officer ...